# CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia

> **NCT03984968** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 40 (estimated)

## Conditions studied

- Acute Lymphoblastic Leukemia, Adult B-Cell

## Interventions

- **BIOLOGICAL:** ssCART-19 cells combined with CD19+ feeding T cells (FTCs) infusion
- **BIOLOGICAL:** ssCART-19 cells combined with CD19+ feeding T cells (FTCs) infusion
- **BIOLOGICAL:** ssCART-19 cells combined with CD19+ feeding T cells (FTCs) infusion
- **BIOLOGICAL:** ssCART-19 cells combined with CD19+ feeding T cells (FTCs) infusion

## Key facts

- **NCT ID:** NCT03984968
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-07-10
- **Primary completion:** 2025-07-20
- **Final completion:** 2040-07-20
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03984968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03984968, "CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-09-01 from https://api.ai-analytics.org/clinical/NCT03984968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*